![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:MAPK1-ATP1A1 (FusionGDB2 ID:HG5594TG476) |
Fusion Gene Summary for MAPK1-ATP1A1 |
![]() |
Fusion gene information | Fusion gene name: MAPK1-ATP1A1 | Fusion gene ID: hg5594tg476 | Hgene | Tgene | Gene symbol | MAPK1 | ATP1A1 | Gene ID | 5594 | 476 |
Gene name | mitogen-activated protein kinase 1 | ATPase Na+/K+ transporting subunit alpha 1 | |
Synonyms | ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK | CMT2DD|HOMGSMR2 | |
Cytomap | ('MAPK1')('ATP1A1') 22q11.22 | 1p13.1 | |
Type of gene | protein-coding | protein-coding | |
Description | mitogen-activated protein kinase 1MAP kinase 1MAP kinase 2MAP kinase isoform p42MAPK 2extracellular signal-regulated kinase 2mitogen-activated protein kinase 2protein tyrosine kinase ERK2 | sodium/potassium-transporting ATPase subunit alpha-1ATPase, Na+/K+ transporting, alpha 1 polypeptideNa(+)/K(+) ATPase alpha-1 subunitNa+/K+ ATPase 1Na, K-ATPase, alpha-A catalytic polypeptideNa,K-ATPase alpha-1 subunitNa,K-ATPase catalytic subunit a | |
Modification date | 20200327 | 20200313 | |
UniProtAcc | . | P05023 | |
Ensembl transtripts involved in fusion gene | ENST00000215832, ENST00000398822, ENST00000491588, ENST00000544786, | ||
Fusion gene scores | * DoF score | 20 X 16 X 10=3200 | 19 X 23 X 5=2185 |
# samples | 24 | 24 | |
** MAII score | log2(24/3200*10)=-3.73696559416621 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(24/2185*10)=-3.18652696877944 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: MAPK1 [Title/Abstract] AND ATP1A1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | MAPK1(22115665)-ATP1A1(116941300), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | MAPK1 | GO:0006468 | protein phosphorylation | 23184662 |
Hgene | MAPK1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 16314496 |
Hgene | MAPK1 | GO:0018105 | peptidyl-serine phosphorylation | 15850461 |
Hgene | MAPK1 | GO:0034198 | cellular response to amino acid starvation | 11096076 |
Hgene | MAPK1 | GO:0038127 | ERBB signaling pathway | 15133037 |
Hgene | MAPK1 | GO:0051403 | stress-activated MAPK cascade | 11096076 |
Hgene | MAPK1 | GO:0070371 | ERK1 and ERK2 cascade | 16314496 |
Hgene | MAPK1 | GO:0070849 | response to epidermal growth factor | 18794356 |
Tgene | ATP1A1 | GO:0006883 | cellular sodium ion homeostasis | 10636900|19542013 |
Tgene | ATP1A1 | GO:0030007 | cellular potassium ion homeostasis | 10636900|19542013 |
Tgene | ATP1A1 | GO:0036376 | sodium ion export across plasma membrane | 10636900|19542013 |
Tgene | ATP1A1 | GO:0071383 | cellular response to steroid hormone stimulus | 11546672 |
Tgene | ATP1A1 | GO:0086009 | membrane repolarization | 19542013 |
Tgene | ATP1A1 | GO:1903416 | response to glycoside | 11546672 |
Tgene | ATP1A1 | GO:1990573 | potassium ion import across plasma membrane | 10636900|19542013 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Top |
Fusion Gene ORF analysis for MAPK1-ATP1A1 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for MAPK1-ATP1A1 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for MAPK1-ATP1A1 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:22115665/:116941300) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | ATP1A1 |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients. {ECO:0000269|PubMed:29499166, ECO:0000269|PubMed:30388404}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for MAPK1-ATP1A1 |
![]() |
Top |
Fusion Gene PPI Analysis for MAPK1-ATP1A1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for MAPK1-ATP1A1 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | ATP1A1 | P05023 | DB00390 | Digoxin | Inhibitor | Small molecule | Approved |
Tgene | ATP1A1 | P05023 | DB00511 | Acetyldigitoxin | Inhibitor | Small molecule | Approved |
Tgene | ATP1A1 | P05023 | DB01078 | Deslanoside | Inhibitor | Small molecule | Approved |
Tgene | ATP1A1 | P05023 | DB01092 | Ouabain | Inhibitor | Small molecule | Approved |
Tgene | ATP1A1 | P05023 | DB01119 | Diazoxide | Other | Small molecule | Approved |
Tgene | ATP1A1 | P05023 | DB01158 | Bretylium | Inhibitor | Small molecule | Approved |
Tgene | ATP1A1 | P05023 | DB01430 | Almitrine | Binder | Small molecule | Approved |
Tgene | ATP1A1 | P05023 | DB13996 | Magnesium acetate | Small molecule | Approved | |
Tgene | ATP1A1 | P05023 | DB14500 | Potassium | Regulator | Small molecule | Approved|Experimental |
Tgene | ATP1A1 | P05023 | DB00903 | Etacrynic acid | Inhibitor | Small molecule | Approved|Investigational |
Tgene | ATP1A1 | P05023 | DB01188 | Ciclopirox | Binder | Small molecule | Approved|Investigational |
Tgene | ATP1A1 | P05023 | DB01345 | Potassium cation | Small molecule | Approved|Investigational | |
Tgene | ATP1A1 | P05023 | DB01370 | Aluminium | Binder | Small molecule | Approved|Investigational |
Tgene | ATP1A1 | P05023 | DB01396 | Digitoxin | Inhibitor | Small molecule | Approved|Investigational |
Tgene | ATP1A1 | P05023 | DB14498 | Potassium acetate | Small molecule | Approved|Investigational | |
Tgene | ATP1A1 | P05023 | DB14499 | Potassium sulfate | Small molecule | Approved|Investigational | |
Tgene | ATP1A1 | P05023 | DB14517 | Aluminium phosphate | Small molecule | Approved|Investigational | |
Tgene | ATP1A1 | P05023 | DB14518 | Aluminum acetate | Small molecule | Approved|Investigational | |
Tgene | ATP1A1 | P05023 | DB00774 | Hydroflumethiazide | Inducer | Small molecule | Approved|Investigational|Withdrawn |
Tgene | ATP1A1 | P05023 | DB01378 | Magnesium cation | Small molecule | Approved|Nutraceutical | |
Tgene | ATP1A1 | P05023 | DB01021 | Trichlormethiazide | Inhibitor | Small molecule | Approved|Vet_approved |
Tgene | ATP1A1 | P05023 | DB01244 | Bepridil | Inhibitor | Small molecule | Approved|Withdrawn |
Top |
Related Diseases for MAPK1-ATP1A1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | MAPK1 | C0009171 | Cocaine Abuse | 2 | CTD_human |
Hgene | MAPK1 | C0020429 | Hyperalgesia | 2 | CTD_human |
Hgene | MAPK1 | C0024121 | Lung Neoplasms | 2 | CTD_human |
Hgene | MAPK1 | C0236736 | Cocaine-Related Disorders | 2 | CTD_human |
Hgene | MAPK1 | C0242379 | Malignant neoplasm of lung | 2 | CTD_human |
Hgene | MAPK1 | C0458247 | Allodynia | 2 | CTD_human |
Hgene | MAPK1 | C0600427 | Cocaine Dependence | 2 | CTD_human |
Hgene | MAPK1 | C0751211 | Hyperalgesia, Primary | 2 | CTD_human |
Hgene | MAPK1 | C0751212 | Hyperalgesia, Secondary | 2 | CTD_human |
Hgene | MAPK1 | C0751213 | Tactile Allodynia | 2 | CTD_human |
Hgene | MAPK1 | C0751214 | Hyperalgesia, Thermal | 2 | CTD_human |
Hgene | MAPK1 | C2936719 | Mechanical Allodynia | 2 | CTD_human |
Hgene | MAPK1 | C0005398 | Cholestasis, Extrahepatic | 1 | CTD_human |
Hgene | MAPK1 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Hgene | MAPK1 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
Hgene | MAPK1 | C0007786 | Brain Ischemia | 1 | CTD_human |
Hgene | MAPK1 | C0017639 | Gliosis | 1 | CTD_human |
Hgene | MAPK1 | C0018671 | Head and Neck Neoplasms | 1 | CTD_human |
Hgene | MAPK1 | C0018675 | Head Neoplasms | 1 | CTD_human |
Hgene | MAPK1 | C0019207 | Hepatoma, Morris | 1 | CTD_human |
Hgene | MAPK1 | C0019208 | Hepatoma, Novikoff | 1 | CTD_human |
Hgene | MAPK1 | C0020564 | Hypertrophy | 1 | CTD_human |
Hgene | MAPK1 | C0021361 | Female infertility | 1 | CTD_human |
Hgene | MAPK1 | C0022665 | Kidney Neoplasm | 1 | CTD_human |
Hgene | MAPK1 | C0023904 | Liver Neoplasms, Experimental | 1 | CTD_human |
Hgene | MAPK1 | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human |
Hgene | MAPK1 | C0027533 | Neck Neoplasms | 1 | CTD_human |
Hgene | MAPK1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | MAPK1 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Hgene | MAPK1 | C0027746 | Nerve Degeneration | 1 | CTD_human |
Hgene | MAPK1 | C0033141 | Cardiomyopathies, Primary | 1 | CTD_human |
Hgene | MAPK1 | C0034189 | Pyemia | 1 | CTD_human |
Hgene | MAPK1 | C0036341 | Schizophrenia | 1 | PSYGENET |
Hgene | MAPK1 | C0036529 | Myocardial Diseases, Secondary | 1 | CTD_human |
Hgene | MAPK1 | C0036690 | Septicemia | 1 | CTD_human |
Hgene | MAPK1 | C0036920 | Sezary Syndrome | 1 | CTD_human |
Hgene | MAPK1 | C0038279 | Sterility, Postpartum | 1 | CTD_human |
Hgene | MAPK1 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Hgene | MAPK1 | C0038587 | Substance Withdrawal Syndrome | 1 | CTD_human |
Hgene | MAPK1 | C0040997 | Trigeminal Neuralgia | 1 | CTD_human |
Hgene | MAPK1 | C0086189 | Drug Withdrawal Symptoms | 1 | CTD_human |
Hgene | MAPK1 | C0086404 | Experimental Hepatoma | 1 | CTD_human |
Hgene | MAPK1 | C0087031 | Juvenile-Onset Still Disease | 1 | CTD_human |
Hgene | MAPK1 | C0087169 | Withdrawal Symptoms | 1 | CTD_human |
Hgene | MAPK1 | C0155862 | Streptococcal pneumonia | 1 | CTD_human |
Hgene | MAPK1 | C0178417 | Anhedonia | 1 | PSYGENET |
Hgene | MAPK1 | C0243026 | Sepsis | 1 | CTD_human |
Hgene | MAPK1 | C0278996 | Malignant Head and Neck Neoplasm | 1 | CTD_human |
Hgene | MAPK1 | C0341869 | Subfertility, Female | 1 | CTD_human |
Hgene | MAPK1 | C0393786 | Trigeminal Neuralgia, Idiopathic | 1 | CTD_human |
Hgene | MAPK1 | C0393787 | Secondary Trigeminal Neuralgia | 1 | CTD_human |
Hgene | MAPK1 | C0740457 | Malignant neoplasm of kidney | 1 | CTD_human |
Hgene | MAPK1 | C0746787 | Cancer of Neck | 1 | CTD_human |
Hgene | MAPK1 | C0751177 | Cancer of Head | 1 | CTD_human |
Hgene | MAPK1 | C0878544 | Cardiomyopathies | 1 | CTD_human |
Hgene | MAPK1 | C0887900 | Upper Aerodigestive Tract Neoplasms | 1 | CTD_human |
Hgene | MAPK1 | C0917730 | Female sterility | 1 | CTD_human |
Hgene | MAPK1 | C0917798 | Cerebral Ischemia | 1 | CTD_human |
Hgene | MAPK1 | C0919267 | ovarian neoplasm | 1 | CTD_human |
Hgene | MAPK1 | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human |
Hgene | MAPK1 | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human |
Hgene | MAPK1 | C1719672 | Severe Sepsis | 1 | CTD_human |
Hgene | MAPK1 | C1866282 | CEROID LIPOFUSCINOSIS, NEURONAL, 6 | 1 | CTD_human |
Hgene | MAPK1 | C3495559 | Juvenile arthritis | 1 | CTD_human |
Hgene | MAPK1 | C3714758 | Juvenile psoriatic arthritis | 1 | CTD_human |
Hgene | MAPK1 | C3887640 | Astrocytosis | 1 | CTD_human |
Hgene | MAPK1 | C4552091 | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1 | CTD_human |
Hgene | MAPK1 | C4704862 | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1 | CTD_human |
Tgene | C0001430 | Adenoma | 2 | CTD_human | |
Tgene | C0205646 | Adenoma, Basal Cell | 2 | CTD_human | |
Tgene | C0205647 | Follicular adenoma | 2 | CTD_human | |
Tgene | C0205648 | Adenoma, Microcystic | 2 | CTD_human | |
Tgene | C0205649 | Adenoma, Monomorphic | 2 | CTD_human | |
Tgene | C0205650 | Papillary adenoma | 2 | CTD_human | |
Tgene | C0205651 | Adenoma, Trabecular | 2 | CTD_human | |
Tgene | C4747974 | CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD | 2 | GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C0005586 | Bipolar Disorder | 1 | PSYGENET | |
Tgene | C0017162 | Gastroenteritis, Transmissible, of Swine | 1 | CTD_human | |
Tgene | C0020428 | Hyperaldosteronism | 1 | CTD_human | |
Tgene | C0020538 | Hypertensive disease | 1 | CTD_human | |
Tgene | C0027051 | Myocardial Infarction | 1 | CTD_human | |
Tgene | C0027055 | Myocardial Reperfusion Injury | 1 | CTD_human | |
Tgene | C0036572 | Seizures | 1 | GENOMICS_ENGLAND | |
Tgene | C0042594 | Vestibular Diseases | 1 | CTD_human | |
Tgene | C0151723 | Hypomagnesemia | 1 | GENOMICS_ENGLAND | |
Tgene | C0151744 | Myocardial Ischemia | 1 | CTD_human | |
Tgene | C1384514 | Conn Syndrome | 1 | CTD_human | |
Tgene | C3714756 | Intellectual Disability | 1 | GENOMICS_ENGLAND | |
Tgene | C4552839 | Hypomagnesemia, CTCAE | 1 | GENOMICS_ENGLAND |